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Summary (173 words) 
 
Involuntary migration is a critical global challenge from an economic, social and public health 
perspective. The number of displaced people reached an unprecedented level in 2015, at a 
total of 60 million worldwide, with over one million crossing into Europe last year alone. 
Migrants and refugees are often perceived to carry a higher load of infectious diseases, 
despite no systematic association. In this viewpoint article we propose three important 
contributions that the global health community can make to help address infectious disease 
risks and global health inequalities worldwide, with a particular focus on the refugee crisis in 
Europe. First, policy decisions should be based on a sound evidence-base regarding health 
risks and burdens to health systems, rather than prejudice or unfounded fears. Second, for 
incoming refugees, we must focus on building inclusive, cost-effective health services to 
promote collective health security. Third, alongside protracted conflicts, widening health and 
socioeconomic inequalities between the developed and developing world should be 
acknowledged as major drivers for the global refugee crisis, and fully considered when 
planning long-term solutions. 
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The United Nations High Commission for Refugees state that the number of displaced 
people globally rose by 16% between 2014 and 2015 – the greatest ever increase in a single 
year - reaching an all-time high of 60 million worldwide1. This figure includes approximately 
38 million internally displaced persons, 20 million refugees and 2 million asylum-seekers. 
Since January 2015, over 1 million people have crossed the Mediterranean to Europe, 
including economic migrants hoping for a better life and refugees fleeing conflicts, political 
upheaval, ethnic discrimination and religious persecution. The continuing swell of refugees 
worldwide is creating an ever-increasing economic and social burden on host countries and 
presents new public health challenges, alongside the deeper humanitarian and social issues. 
With such mass involuntary migration - and the associated overcrowding, poor sanitation 
and limited access to clean water – often comes a substantial increase in risk of infectious 
disease outbreaks, depending on the context. For example, following an official declaration 
of cholera outbreaks in Iraq from September 2015 and with the continued degradation of 
health service and surveillance infrastructure in neighbouring Syria, the risk of disease 
contagion and large-scale outbreaks occurring in the wider region is increasing.2  
 
The overwhelming burden of hosting large populations of displaced people, and managing 
potential infectious disease risks associated with their influx has, for decades, fallen on low 
and middle-income countries (LMICs). Between 2009 and 2013, for example, 86% of all 
refugees were hosted in LMICs, many of which already face a substantial infectious disease 
burden.1 The number of refugees hosted by LMICs is more than five times the number 
hosted by the ten richest countries within the Organization for Economic Cooperation and 
Development (OECD) [see figure].3,4 Turkey, Pakistan, Lebanon and Iran together host a 
staggering 5.2 million refugees.5 Political, infrastructural and financial constraints in LMICs 
have frequently been obstacles to providing access to health services and infectious disease 
screening programmes for the refugee populations. Constraints in the host countries have 
often had to be mitigated through support from UNHCR and other international 
organisations. 
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With refugees now being forced to migrate into the developed world - most notably to 
Europe - the issue has rapidly risen up the global political agenda. The World Economic 
Forum now, unsurprisingly, ranks involuntary migration one of the greatest risks to the world 
economy.6 However, in some of these developed countries, migrants and refugees have 
been coalesced into a single emotive security issue, with the risk that policies ignore other 
softer, but equally important issues such as collective health security that can only be 
guaranteed by social integration and more equitable access to health care.  
 
Following recent terrorist attacks in Turkey, Lebanon, France and Belgium and media 
reports of sexual and physical assaults in Europe, there is a danger that exaggerated 
associations will be drawn between refugees, terrorism and criminality; and that as a result, 
policies and interventions in industrialised countries receiving refugees will be increasingly 
framed primarily in relation to risks to national security rather than equity and global health 
security.   
We propose three broad contributions that could be made by the global health community to 
help assess, better inform and reduce potential infectious disease risks associated with 
incoming refugees, and improve social integration in relation to the refugee crisis in Europe.  
 
First: ensuring that evidence is obtained about the true infectious disease risks from 
refugees and the burden they cause to health systems in order to prevent prejudicial 
concerns and unfounded stigmatisation.  
Many refugees come from areas with high poverty levels and weak health systems, and 
several European countries are concerned about refugees bringing previously controlled 
infections within their borders. The arduous journey that many refugees have endured may 
increase their risk of infectious diseases, particularly measles and food and water borne 
diseases to which they are at increased risk if immunization programs in their countries of 
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origin have been interrupted.7 However, despite the commonly held view of an association 
between migration and spread of infectious diseases, there is no systematic association with 
many of the infectious diseases of concern. For example, enteric fever is already reported in 
the European region with the vast majority of cases occurring in returning travellers rather 
than refugees or migrants. The risk of other infectious diseases including viral haemorrhagic 
fevers or the Middle East Respiratory Syndrome (MERS) is also low with most cases 
occurring in healthcare workers or travellers rather than refugees. 7 The threat of infectious 
disease outbreaks from current population movements into Europe may thus be substantially 
less than perceived.  
Any misinformation exaggerating the health and infectious disease risks associated with 
incoming refugees must be firmly countered with data-driven epidemiology and a pragmatic 
approach to disease control, and the evidence must be clearly provided, and understood by 
politicians and the general public. To generate a strong evidence base, a coordinated 
approach to health needs assessments and surveillance should be developed, leveraging 
institutional networks such as the European Centre for Disease Control and its links to 
reference laboratories and individual national public health agencies. Estimating the 
infectious disease risk to Europe from cholera, for example, should take into account the well 
developed public water and sanitation systems, excellent health infrastructure, and well-
integrated and responsive disease surveillance networks, all of which substantially reduce 
the chances of large outbreaks of cholera. Communicating infectious disease risk 
assessments to the general public and policymakers accurately is thus key to rationalising 
the broader debate around the issue.   
 For example, concerns about transmission of polio from Syrian refugees into Europe 
following the 2013-4 outbreak of polio were unfounded. Although cases traceable to Syria 
were identified in Iraq8 no cases were identified in asymptomatic toddlers screened in 
Germany9 Yet, both the medical10 and lay press had extensively discussed the ‘polio threat’ 
in view of low vaccination rates in the UK and Germany. What these reports failed to 
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consider was the ability of the global system to respond appropriately. The global response 
in that instance was measured, and risk communication on the whole was effective, with the 
declaration of a Public Health Emergency of International Concern. The declaration brought 
the Global Polio Eradication Initiative (WHO) together with different organisations to perform 
multiple rounds of vaccination in affected areas and was effective at controlling the outbreak 
and minimising risk of spread.  
Similarly, for another infectious disease of concern, tuberculosis (TB), the potential for 
spread and disease progression will likely be reduced in the European population - as 
compared to low resource settings - owing to improved nutritional status and housing 
conditions. Most refugees currently entering Europe come from Syria, which had a TB 
prevalence of 23 per 100,000 in 2011 and 19 per 100,000 in 201411,12.TB prevalence in Syria 
is thus lower than the average rate in the European region of 39 per 100,000 population13, 
and substantially below numerous European countries [see table]3,4.  Furthermore, 
transmission from refugees to local populations does not occur often due to limited contact 
and early diagnosis and effective care of TB will further minimise risk. Indeed, studies in low 
tuberculosis burden countries such as Denmark have indicated that transmission from 
refugees to local populations is limited, and that refugees are more likely to be infected by 
local populations than vice versa14.  
 
Thus, the evidence indicates that the infectious disease risks to Europe are limited, and this 
needs to be effectively communicated to both host communities and the incoming refugees.  
 
Second: we strongly recommend ensuring access to health care for all refugees and 
migrants through: regular health checks for both communicable and non communicable 
diseases (NCDs); hospitable and high-quality health care preventative and curative services 
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without discrimination on the basis of gender, age, religion, nationality or race; and cost-
effective, culturally appropriate approaches maintaining human rights and dignity.  
The WHO emphasizes that results of screening should not be a reason for deporting the 
refugee 7. Refugees have suffered long and arduous stressful journeys enduring cramped, 
unhygienic environments which take a toll on their mental and physical health and existing 
NCDs. Many European countries, including the United Kingdom, request medical screening 
in the host country and then perform further screening of refugees on arrival; this includes 
targeted TB screening for those in the UK.15 The US has an established program of 
mandatory screening refugees both pre-departure and post-arrival to determine 
immunization status, the presence of parastic infections and other communicable 
diseases.16,17 A review of the stratetgy of post-arrival screening amonst Iraqi refugees in the 
US performed between 2008 and 2009 identified rates of latent TB infection at 14.1% and, 
importantly, noted that despite the traditional focus of refugee medical screening, morbidity 
owing to NCDs was of higher prevelance.18 This is mirrored in other refugee populations 
from the MENA (Middle and Near East) region, particular those of Syrian origin, where NCDs 
are more prevalent than infectious diseases.  
 
WHO, thus rightly, does not recommend compulsary mass screening of refugee or migrant 
populations, though it does recommend health checks for both infectious diseases and 
NCDs and access to health services whilst mainting the dignity of the refugees and migrants. 
There is no evidence that mass compulsory checks have a benefit or are cost-effective, and 
they carry the risk of causing anxiety to individuals and detering refugees and migrants from 
seeking healthcare7. Screening programmes should be rationalised and prioritised for 
incoming refugees from high burden settings, for conditions where they have been 
demonstrated to be effective, 19 rather than attempting to cover all arrivals particularly where 
local services are being overwhelmed by volume. Post-arrival screening and assessment of 
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immunization status may be particularly important to reduce the risk of outbreaks, 
particularly if refugees originate from areas where vaccination programs are interrupted.  
 
Promoting refugees’ access to appropriate and culturally acceptable health services, and 
encouraging their integration is, we believe, fundamental to ensuring Europe’s collective 
health security. This can only be achieved if incoming refugees feel welcome and not the 
subject of stigmatisation, or persecution.7 Experience from around the world demonstrates 
that many refugee groups – such as Myanmar’s Rohingya minority – have long been 
deprived of essential healthcare in their homeland, and arrive in host countries in extremely 
poor health. Exacerbating these poor baseline health conditions by providing inadequate 
health services at refugee reception or processing centres can thus become a risk to the 
collective health of host populations; for example conditions in Australia’s Nauru and Manus 
Island detention centres for ‘offshore processing’ has resulted in outbreaks of infectious 
diseases.20 In contrast, the strong vaccination surveillance system in Germany identified low 
measles immunisation rates amongst incoming refugees to Lower Saxony and measures are 
being taken to vaccinate arriving groups, illustrating how evidence can be used to reduce 
health inequalities among refugees and host communities. The European Vaccine Action 
Plan 2015-2020 (EVAP) details the importance of equitable access to vaccination and to 
encourage access for refugees and migrants with culturally appropriate services. 7 
High-income countries have all the ingredients (experience, knowledge and resources) to 
find cost-effective solutions to health challenges that might arise from incoming refugees, as 
well as the institutional strength and innovative capacity to integrate and harness the 
potential socioeconomic benefits of these incoming groups. Innovative solutions to 
strengthen the control of infectious diseases in refugee populations could include mobile 
diagnostic and surveillance units – similar to the ‘Find and Treat’ service for tuberculosis in 
the homeless and disadvantaged in London21 with an integrated support function for 
psychosocial care, and new public-private partnerships for health surveillance, delivery of 
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health promotion messaging and phone-based incentives, and signposting of essential 
health services.  There may also be lessons to be learnt from the large US refugee 
resettlement programme 17,22 and the Electronic Disease Notification System in operation 
since 2006 that has demonstrably improved the timeliness and accuracy of infectious 
disease notifications. Further studies should however, include economic analyses taking into 
account longterm outcomes for conditions such as latent TB infections detected amongst 
incoming refugees.  
 
In Sweden, where over 100,000 refugees were taken in over 2015 alone, creative 
approaches to integrating refugee communities, improving health literacy and ensuring 
adequate access to health services are also being trialled. With many refugees, from Syria in 
particular, already medically trained, Sweden has introduced a number of fast-track schemes 
to integrate these refugee healthcare workers into the labour market, thus addressing 
problems associated with staff shortages, language barriers and cultural sensitivity.23 
 
For interventions to be effective, however, improved coordination and cooperation is needed 
across European countries. An important step in this direction has recently been taken by 
European States and the European Commission with support from WHO Europe; the 
publication of a joint statement on addressing the health needs of incoming refugees to 
Europe24 and the development of a patient health record that will be piloted at borders for 
evaluating refugees’ medical needs and reconstructing their medical history.25 A joint 
technical statement by UNHCR-WHO-UNICEF on vaccination for refugees entering Europe 
provides further support on harmonizing and developing consist standards across the region. 
These efforts are important and build on the continuing work of the WHO Europe Public 
Health Aspects of Migration in Europe (PHAME) project26 that has developed both evidence-
based guidance and a series of tools to assist countries in assessing and addressing the 
health needs of migrant and refugee populations.  Unfortunately, amongst European Union 
member states, the effectiveness of these initiatives continues to be limited by the 
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insufficient financial and political commitment to improve cross-border coordination around 
the health needs of refugees. 
 
Third: helping political leaders understand and acknowledge that alongside conflict and 
violence, widening socioeconomic and health inequalities (i.e. the broader determinants of 
health) between and within countries – a global phenomenon - is one principal driver for 
refugee migration; development initiatives must thus focus on improving health systems, 
transparency, governance and political stability in the countries from which refugees derive. 
The recent European Union agreement to provide USD 1.9 billion to address the drivers of 
outward migration from Africa, implied some recognition of this.27 Hopefully, some of that 
spend could be used to support more equitable structuring of economic and commercial 
agreements between the developed and developing world and a more equal sharing of 
profits. Turkey has now been promised a further USD 3.2 billion to stem the outward flow of 
refugees into Europe, but these funds are being directed more at border security and have 
not been sufficiently aimed at addressing this underlying driver - health and socioeconomic 
inequalities experienced by refugees in unstable environments.28  
Leaders in European countries and other destination regions for refugees need to develop 
an improved awareness and understanding of this driver and resist measures that 
compound inequalities both abroad and at home. The recently concluded Department of 
Health consultation on extending charges to visitors, refugees and migrants accessing 
primary and secondary care services in the UK, conducted with limited public or professional 
engagement,29 highlights some of the prevailing attitudes developing across Europe that 
threaten collective health security. It demonstrates a continuing erosion of the founding 
principles of the UK National Health Service, framed around reducing inequalities through 
universal health coverage, free at the point of access. If implemented as planned, the 
measures will likely lead to late diagnosis of medical conditions, including of infectious 
diseases (though these are exempt from further charges once a diagnosis has been made), 
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and worse health outcomes for refugees and migrants as the poorest groups delay 
accessing services to limit costs. 
In summary, one fundamental long-term solution to the refugee crisis, and the associated 
potential infectious disease challenges for countries that receive refugees, is for those more 
economically fortunate countries to increase efforts to reduce the health and socioeconomic 
inequalities that drive populations to become refugees. But to ensure collective health 
security and prevent disease outbreaks in countries receiving refugee populations today, the 
short term solution must be to engage much better with those who have already arrived, and 
those who will continue to arrive for the foreseeable future. Measures to address health 
inequalities, through improved disease risk assessment, better access and a more culturally 
sensitive health service support both refugee integration and help reduce threats from 
infectious diseases. Such measures must be viewed as a key component within any broader 
security strategy.  
The 1920 Aliens' Order barred entry into Britain of immigrants with a range of medical 
conditions. This was reversed during the World Refugee Year (1959-60), and allowed entry 
to refugees who had tuberculosis and other chronic illnesses.30 Given the numbers of 
refugees worldwide has only increased in the years since, we now have an even greater 
collective responsibility to helping address the current crisis. The refugee situation is not all 
doom and gloom and there are many who have readily engaged and are actively 
contributing to improving the lives of displaced populations,31,32 thereby reaffirming our own 
humanity and a shared commitment to a more equal world. 
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